__NUXT_JSONP__("/drugs/Alpha_V_Beta_1_Inhibitor_ATN-161", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A small peptide antagonist of integrin alpha5beta1 with potential antineoplastic activity. ATN-161 selectively binds to and blocks the receptor for integrin alpha5beta1, thereby preventing integrin alpha5beta1 binding. This receptor blockade may result in inhibition of endothelial cell-cell interactions, endothelial cell-matrix interactions, angiogenesis, and tumor progression. Integrin alpha5beta1 is expressed on endothelial cells and plays a crucial role in endothelial cell adhesion and migration.",fdaUniiCode:"XW0H5LE42K",identifier:"C52185",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C2050"],synonyms:["ATN-161",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAlpha_V_Beta_1_Inhibitor_ATN-161",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Alpha_V_Beta_1_Inhibitor_ATN-161","Alpha V Beta 1 Inhibitor ATN-161","2021-10-30T13:40:32.753Z")));